AstraZeneca opens new Massachusetts R&D center as part of $1 billion investment
7 Articles
7 Articles
AstraZeneca to invest over $1 billion in Massachusetts, boost workforce
AstraZeneca said on Monday it would spend more than $1 billion in Massachusetts as part of its broader $50 billion US investment plan, a move expected to expand its workforce in the state by more than 50% in the coming years.
The current investment concerns a new research and development center in Cambridge, a move that is expected to increase its human resources in that state by more than 50% in the coming years.
AstraZeneca Opens New Global R&D Center in Cambridge’s Kendall Square
$1 billion Massachusetts investment will expand the company’s state workforce by more than 50% and support research into next-generation medicines CAMBRIDGE, Mass. — AstraZeneca has opened a new global strategic […]
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium













